Cargando…
An increase in acute heart failure offsets the reduction in acute coronary syndrome during coronavirus disease 2019 (COVID‐19) outbreak
Autores principales: | Sulzgruber, Patrick, Krammel, Mario, Aigner, Patrick, Pfenneberger, Georg, Espino, Albert, Stommel, Johannes, Herbich, Klaus, Hofer, Felix, Kazem, Niema, Koller, Lorenz, Hengstenberg, Christian, Niessner, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835600/ https://www.ncbi.nlm.nih.gov/pubmed/33179444 http://dx.doi.org/10.1002/ehf2.13115 |
Ejemplares similares
-
The Impact of Preclinical High Potent P2Y(12) Inhibitors on Decision Making at Discharge and Clinical Outcomes in Patients with Acute Coronary Syndrome
por: Hammer, Andreas, et al.
Publicado: (2023) -
The age-specific prognostic impact of the platelet-to-lymphocyte ratio on long-term outcome after acute coronary syndrome
por: Kazem, Niema, et al.
Publicado: (2021) -
The prognostic impact of left ventricular thrombus resolution after acute coronary syndrome and risk modulation via antithrombotic treatment strategies
por: Hofer, Felix, et al.
Publicado: (2021) -
Cardiogenic Shock Does Not Portend Poor Long-Term Survival in Patients Undergoing Primary Percutaneous Coronary Intervention
por: Steinacher, Eva, et al.
Publicado: (2022) -
The Prognostic Impact of Circulating Regulatory T Lymphocytes on Mortality in Patients with Ischemic Heart Failure with Reduced Ejection Fraction
por: Hammer, Andreas, et al.
Publicado: (2020)